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Gelonin inhibits protein synthesis by inactivating the eukaryotic 60 S ribosomal subunit by an unknown 
mechanism. The protein was purified in high yield by a new method using Cibacron blue F,GA-Sepharose. 
Chemical modification studies reveal that arginine residues are essential for biological activity. 
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1. INTRODUCTION 
Proteins which inactivate eukaryotic ribosomes 
in a manner similar to ricin have been isolated and 
characterized from several plants [l]. These 
ribosomal inactivating proteins (RIPS) inhibit pro- 
tein synthesis by enzymatically inactivating the 
60 S ribosomal subunit. Despite considerable ef- 
forts, toxin-induced changes in the RNA or protein 
molecules of the 60 S ribosomal subunit have not 
been identified and their exact mechanism of ac- 
tion is unknown. 
Much interest in the study of these proteins 
derives from their potential use in the synthesis of 
immunotoxins [2]. Gelonin, a prototype of the A 
chain toxin, has been purified earlier and some of 
its properties have been reported [3]. It has been 
chemically coupled to lectins and antibodies to 
generate cytotoxic molecules [4]. However, very 
little information is available on the structural 
features essential for biological activity. Detailed 
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Abbreviations: CHD, cyclohexane-1,2-dione; CD, cir- 
cular dichroism; SDS-PAGE, SDS-polyacrylamide gel 
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phosphate-buffered saline 
structure-activity correlation studies of these pro- 
teins are essential, not only for understanding the 
nature of their combining site, but also for the 
design and synthesis of more potent toxin con- 
jugates. Chemical modification of various amino 
acid side chains is one of the very useful methods 
for identifying residues involved at the active site. 
Here, gelonin has been purified in high yields by 
a new method, the amino acid residues modified 
using specific reagents and the effects of these 
chemical modifications on its biological activity in- 
vestigated. Such studies indicate that arginine 
residues are essential for manifestation of the 
biological activity of gelonin. 
2. MATERIALS AND METHODS 
2.1. Materials 
Seeds of Gelonium multiflorum were obtained 
from United Chemicals, Calcutta. [3H]Leucine of 
specific activity 182 Ci/mmol was obtained from 
Amersham Radiochemical Centre. Succinic 
anhydride, CHD and 2-hydroxy-5-nitrobenzyl 
bromide were obtained from Pierce. Ethoxyformic 
anhydride and N-bromosuccinimide were from 
Sigma. SDS-PAGE molecular mass markers were 
from Pharmacia. Synthesis of p-nitrophenyl- 
glyoxal was as described [5]. 
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2.2. Purification of gelonin 
Gelonin was purified by chromatography on 
Cibacron blue F3GA-Sepharose columns. The dye 
was coupled to Sepharose as described in [6] and 
the details of purification are described in fig.lA. 
2.3. In vitro protein synthesis 
The biological activity of gelonin was assayed by 
its ability to inhibit protein synthesis in the rabbit 
reticulocyte lysate assay system as described [7]. 
2.4. Amino acid analysis 
Gelonin was hydrolysed in evacuated sealed am- 
poules with 6 N HCl at 100°C for 24 h. Amino 
acid analyses were performed in duplicate on an 
LKB 4400 amino acid analyser. 
2.5. Circular dichroism studies 
CD spectra were recorded on a Jasco J-20 
automatic recording spectropolarimeter. Protein 
concentration was 200 pg/ml. Solutions were 
made in 0.1 M NaCl, 10 mM sodium phosphate 
buffer, pH 7.2 (PBS), and a 5 mm path length cell 
was used. 
2.6. Protein estimation 
Protein estimations were performed by the 
method of Lowry et al. [8] or by,Bradford’s dye 
binding procedure [9]. 
2.7. Preparation of antisera 
Rabbits were immunized at biweekly intervals 
with 1 mg each of gelonin in complete Freund’s 
adjuvant. Booster injections were 100 fig protein in 
incomplete Freund’s adjuvant. Immune sera were 
collected and IgG prepared as described [lo]. 
2.8. Chemical modification studies 
The various amino acid side chains were 
modified as described below. After modification, 
excess reagent was removed by gel filtration on 
Sephadex G-25 columns (20 x 1 cm) equilibrated 
in PBS. 
2.8.1. Modification of lysine residues 
The lysine side chains were modified using suc- 
cinic anhydride [I l] or citraconic anhydride [12]. 
To the protein (2 mg/ml in 50% saturated 
NaHCOj solution, pH 8.0) was added a 300 M ex- 
cess of either reagent. The solution was stirred at 
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4°C for 1 h and the pH maintained at 8.0. Reduc- 
tive methylation was carried out as described [13]. 
The percentage of modification of the lysine f- 
amino groups was assessed using 2,4,6_trinitroben- 
zenesulphonic acid [ 141. 
2.8.2. Modification of arginine residues 
Gelonin (2 mg) in 3 ml of 0.1 M sodium 
pyrophosphate, 0.15 M sodium ascorbate, pH 9.0, 
was reacted with 25 ~1 of a 10% methanol solution 
of p-nitrophenylglyoxal for 30 min at 30°C. The 
extent of modification was determined as de- 
scribed [ 151. Alternatively the arginine residues 
were modified with CHD as described [16]. Pro- 
tein (2 mg/ml) in 0.2 M borate buffer, pH 9.0, was 
reacted with a 200 M excess of a methanol solution 
of CHD. The reaction was carried out in the dark 
under N2 for 18 h. The number of unreacted 
arginine residues remaining after modification 
with CHD was estimated using p-nitrophenyl- 
glyoxal. The reaction with CHD was reversed with 
hydroxylamine at pH 7.0 as described [ 161. 
2.8.3. Modification of tyrosine, tryptophan, 
histidine and carboxyl residues 
For modification of tyrosine residues 2 mg/ml 
of gelonin in 0.01 M phosphate buffer, pH 7.5, 
was treated with 300 M excess of N- 
acetylimidazole at 5°C for 1 h. The extent of 
modification was estimated as described [17]. 
Modification of tryptophan residues was carried 
out with 2 mg/ml of protein in 0.1 M sodium 
acetate buffer, pH 4.0, as described using N- 
bromosuccinimide in the absence of urea [18] or 
with 2-hydroxy-5-nitrobenzyl bromide in the 
presence of 8 M urea [19]. 
Modification of histidine residues was carried 
out as described using ethoxyformic anhydride 
[20]. Carboxyl groups were modified using 
[‘4C]glycine methyl ester [21]. 
3. RESULTS 
3.1. Purification of gelonin 
Gelonin eluted on Cibacron blue F3GA- 
Sepharose columns at 0.7 M NaCl (fig.lA). The 
protein thus obtained was pure and had an ap- 
parent molecular mass of 30 kDa on SDS-PAGE 
gels (fig.lB). Yields of gelonin were high; 60 mg 










Fig. 1. (A) Chromatography of gelonin on Cibacron blue F3GA-Sepharose. About 150 ml (780 mg protein) of a crude 
homogenate of Gelonium multiforum seeds in 0.1 M NaCl, 10 mM phosphate buffer, pH 7.2 (PBS) was loaded on 
a 100 ml column of gel. The column was washed with PBS and eluted with a gradient of NaCl in PBS (0.1-1.0 M), 
250 ml each. Fractions containing protein were pooled and lyophilized. (B) SDS-PAGE of purified protein. Gel 1: 
molecular mass markers (in kDa): phosphorylase b (94), BSA (67), ovalbumin (43), carbonic anhydrase (30), ,& 
lactalbumin (21). Gelonin (20 pg) was loaded in gel 2. Electrophoresis was according to the procedure of Laemmli (241. 
pure protein were obtained from 10 g seeds. 
Purified samples can be stored indefinitely at 
-20°C without any loss of activity. 
3.2. Modification studies 
The results of the chemical modification of 
various amino acid side chains of gelonin are 
shown in table 1. It is apparent hat the biological 
activity of the protein is unaffected by a variety of 
chemical treatments. Extensive modification of the 
e-amino groups of lysine or histidine side chains 
did not result in any significant decrease in its 
biological activity. Modification of either the 
tyrosine or carboxyl residues also did not affect the 
activity. 
Modification of the single tryptophan residue 
with 2-hydroxy-5-nitrobenzyl bromide in the 
presence of urea did not affect the enzymatic ac- 
tivity of gelonin. This single tryptophan residue 
was not oxidised with N-bromosuccinimide sug- 
gesting that it is buried in the hydrophobic interior 
of the protein molecule, inaccessible to the 
reagent. 
Modification of the arginine residues with either 
p-nitrophenylglyoxal or CHD, reagents specific 
for these residues, led to 80 and 70% loss in 
biological activity, respectively. All 10 arginine 
residues of the protein were modified with p- 
nitrophenylglyoxal, and 9 residues with CHD, in- 
dicating that most of the arginine residues are ex- 
posed on the hydrophilic surface of the molecule. 
Reversal of the modification with CHD using 
hydroxylamine led to a complete recovery of ac- 
tivity. Thus the observed loss of biological activity 
is exclusively due to modification of arginine 
residues. 
Fig.2 shows the inhibition of protein synthesis 
by gelonin as a function of the number of arginine 
residues modified with CHD. Gelonin was reacted 
with CHD and at the different time intervals in- 
dicated, samples were estimated for both the 
number of arginines modified and their ability to 
inhibit protein synthesis. Two of the 10 arginine 
residues could be modified without loss of activity. 
Subsequent modification, however, led to a 
dramatic loss in activity. Thus from l-2 h of reac- 
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Chemical modifications of gelonin 
Reagent Residue 
modified” 
% modifi- Protein 
cation synthesis 
(mol/mol (o/o control) 
protein) 
Succinic anhydride LYS (18) 70 80 
Citraconic anhydride Lys 60 80 
Formaldehyde + sodium borohydride Lys 55 90 
p-Nitrophenylglyoxal Arg (10) 100 20 
Cyclohexanedione Arg 90 25 
Cyclohexanedione + NHzOH (pH 7.0) Arg 0 90 
N-Acetylimidazole Tyr (8) 60 80 
2-Hydroxy-5-nitrobenzyl bromide Trp (1) 100 90 
N-Bromosuccinimide Trp - 90 
Ethoxyformic anhydride His (2) 100 95 
[r4C]Glycine methyl ester Clu,Asp (48) 30 93 
a Numbers in brackets indicate number of amino acid residues present in native gelonin as 
determined by amino acid analysis 
Gelonin, 2 mg (60rM), was reacted with the various reagents essentially as described. After 
the reaction, samples were chromatographed on Sephadex G-25 columns to remove free 
reagent. Control samples were treated similarly except no modifying reagent was added. 
Modified and control samples were tested for their ability to inhibit protein synthesis using 
the rabbit reticulocyte lysate assay described [7]. The same final concentration (160 nM) of 
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Fig.2. Gelonin (2 mg) in 1 ml of 0.2 M borate buffer, 
pH 9.0, was treated with 200 M excess of CHD in 
methanol. At the different time intervals indicated, 
samples were chromatographed on Sephadex G-25 
superfine columns in PBS, dialysed and lyophilized. The 
extent of modification and the activity of control and 
modified samples were determined as described in the 
text. 
tion with CHD there was a 90% loss of activity 
when a total of 4 arginine residues were modified. 
There was no further change in activity when the 
remaining 6 residues were modified. 
The observed loss of activity could be the result 
of a conformational change in the molecule 
following modification. CD measurements and im- 
munodiffusion studies were carried out to in- 
vestigate the conformational changes, if any, 
resulting from chemical modification of the 
arginine residues. 
The far-UV CD spectra (fig.3A) of native 
gelonin and gelonin wherein all the arginine 
residues had been modified with CHD (18 h reac- 
tion) are almost superimposable. Thus the ob- 
served loss of activity following modification is a 
direct result of the modifying reaction and not due 
to any gross conformational change. 
Fig.3B shows that antibodies raised to native 
gelonin cross-reacted with the arginine modified 
protein giving lines of total immunological identi- 
ty. This also rules out the possibility that the 
observed loss of biological activity is due to a 
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Fig.3. (A) CD spectra of arginine-modified (---) and 
native (-) gelonin. Modified protein sample had 
been treated with CHD for 18 h. (B) Double 
immunodiffusion of native and arginine modified 
gelonin. Plates were made in 1% agarose in PBS. 
Central well contained purified anti-gelonin IgG 
(100 gg); wells 1 and 2 contained 20 gg each of native 
and modified protein, respectively. 
change in the conformation of the protein follow- 
ing modification. 
4. DISCUSSION 
Using visible difference absorption spectroscopy 
it has been shown that ricin A chain binds 
specifically to the dye Cibacron blue F3GA [22]. 
We have found that gelonin, an A chain toxin, also 
interacts specifically with the dye molecules im- 
mobilized on Sepharose. The protein can be 
purified in a single step using Cibacron blue F3GA- 
Sepharose columns. The yields of gelonin by this 
method are 6-fold higher than that reported by 
Stirpe et al. [3] using CM-cellulose columns. The 
tremendous interest generated recently in the syn- 
thesis and use of immunotoxins should make dye- 
Sepharose affinity chromatography a very useful 
method to purify other A chain toxins. 
Chemical modification studies of gelonin were 
undertaken to determine the amino acid residues 
essential for its biological activity. Gelonin is par- 
ticularly amenable to such studies because of its 
ease of purification and extreme stability to a 
variety of chemical treatments. Modification of 
lysine, tyrosine, tryptophan, histidine and carbox- 
yl groups had no effect on the biological activity of 
gelonin. Modification of the arginine residues 
alone led to a drastic loss of activity. This loss of 
activity was fully restored on treatment with 
hydroxylamine which reverses the modification. 
The arginine residues of gelonin fall into 3 classes. 
Modification of the first 2 residues had no effect 
on activity, whereas modification of the second set 
of 2 led to a dramatic loss of activity. The remain- 
ing 6 residues could be modified with practically 
no change in activity. 
Phenylglyoxal, 2,3-butanedione and CHD have 
been used for modification of arginine residues, 
the latter 2 being even more specific than 
phenylglyoxal. We have obtained comparable 
results using both sets of reagents, though the reac- 
tion with p-nitrophenylglyoxal is much more rapid 
than the dicarbonyl reagents. The unreacted 
arginine residues after CHD treatment can be easi- 
ly monitored using p-nitrophenylglyoxal instead of 
the more tedious procedure of amino acid analysis. 
Both CD data and immunodiffusion studies in- 
dicate that the loss of activity following arginine 
modification was not due to a drastic conforma- 
tional change. Thus the loss of activity on 
modification of arginine residues was due to 
modification per se. 
In a similar study, the involvement of histidine 
and possibly arginine residues in the biological ac- 
tivity of another A chain toxin from pokeweed has 
been suggested [23]. However, no conclusive 
evidence for the involvement of these residues in 
biological activity was presented. The possibility of 
the involvement of arginine residues in the 
biological activity of a variety of A chain plant tox- 
ins remains to be investigated. 
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